Next, we assessed APOC1 expression in lymphoma tissues from 46 DLBCL patients using RT-qPCR and Western blot, with lymph node tissues from 13 RHL patients (a benign tumor) serving as negative controls. Here, APOC1 is linked to neoplasm.